BioLineRx Ltd. BLRX
$ 0.2
0.5%
Annual report 2023
added 12-21-2024
Country |
Israel |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Philip Serlin |
Employees in the company |
42 |
Shares |
- |
Market Cap[1] |
$ 908 M |
EBITDA (LTM) |
$ -24.3 M |
P/E (LTM) |
-4.62 |
P/S (LTM) |
- |
EPS (LTM) |
-0.13 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.